ID MMP24_HUMAN Reviewed; 645 AA. AC Q9Y5R2; B7ZBG8; Q9H440; DT 24-JAN-2001, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1999, sequence version 1. DT 27-MAR-2024, entry version 202. DE RecName: Full=Matrix metalloproteinase-24; DE Short=MMP-24; DE EC=3.4.24.-; DE AltName: Full=Membrane-type matrix metalloproteinase 5; DE Short=MT-MMP 5; DE Short=MTMMP5; DE AltName: Full=Membrane-type-5 matrix metalloproteinase; DE Short=MT5-MMP; DE Short=MT5MMP; DE Contains: DE RecName: Full=Processed matrix metalloproteinase-24; DE Flags: Precursor; GN Name=MMP24; Synonyms=MT5MMP; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC TISSUE=Brain; RX PubMed=10363975; RA Llano E., Pendas A.M., Freije J.P., Nakano A., Knaeuper V., Murphy G., RA Lopez-Otin C.; RT "Identification and characterization of human MT5-MMP, a new membrane-bound RT activator of progelatinase a overexpressed in brain tumors."; RL Cancer Res. 59:2570-2576(1999). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Seiki M.; RT "Identification of a new membrane-type matrix metalloproteinase, MT5-MMP, RT that is expressed predominantly in cerebellum."; RL Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=11780052; DOI=10.1038/414865a; RA Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., RA Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., RA Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., RA Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D., RA Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G., RA Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E., RA Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D., RA Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P., RA Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E., RA Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J., RA Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D., RA Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S., RA Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D., RA Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A., RA Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T., RA Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I., RA Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M., RA Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D., RA Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M., RA Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A., RA Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L., RA Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L., RA Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 20."; RL Nature 414:865-871(2001). CC -!- FUNCTION: Metalloprotease that mediates cleavage of N-cadherin (CDH2) CC and acts as a regulator of neuro-immune interactions and neural stem CC cell quiescence. Involved in cell-cell interactions between nociceptive CC neurites and mast cells, possibly by mediating cleavage of CDH2, CC thereby acting as a mediator of peripheral thermal nociception and CC inflammatory hyperalgesia. Key regulator of neural stem cells CC quiescence by mediating cleavage of CDH2, affecting CDH2-mediated CC anchorage of neural stem cells to ependymocytes in the adult CC subependymal zone, leading to modulate their quiescence. May play a CC role in axonal growth. Able to activate progelatinase A. May also be a CC proteoglycanase involved in degradation of proteoglycans, such as CC dermatan sulfate and chondroitin sulfate proteoglycans. Cleaves CC partially fibronectin, but not collagen type I, nor laminin (By CC similarity). {ECO:0000250}. CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250}; CC Note=Binds 1 zinc ion per subunit. {ECO:0000250}; CC -!- COFACTOR: CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250}; CC -!- SUBUNIT: Interacts (via PDZ-binding motif) with APBA3 (via PDZ domain). CC Interacts with GRIP1 and GRIP2 (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Matrix metalloproteinase-24]: Cell membrane CC {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Golgi CC apparatus, trans-Golgi network membrane {ECO:0000250}; Single-pass type CC I membrane protein {ECO:0000250}. Note=Recycled back to the plasma CC membrane through the trans-Golgi network via interaction with APBA3. CC {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Processed matrix metalloproteinase-24]: CC Secreted, extracellular space, extracellular matrix {ECO:0000250}. CC Note=Also shed from cell surface as soluble proteinase, by a CC proteolytic cleavage. {ECO:0000250}. CC -!- TISSUE SPECIFICITY: Predominantly expressed in brain, kidney, pancreas CC and lung. Overexpressed in a series of brain tumors, including CC astrocytomas and glioblastomas. {ECO:0000269|PubMed:10363975}. CC -!- DOMAIN: The conserved cysteine present in the cysteine-switch motif CC binds the catalytic zinc ion, thus inhibiting the enzyme. The CC dissociation of the cysteine from the zinc ion upon the activation- CC peptide release activates the enzyme. CC -!- DOMAIN: The PDZ-binding motif (also named EWV motif) is required for CC interaction with PDZ domains of APBA3 and recycling through the trans- CC Golgi network. {ECO:0000250}. CC -!- PTM: Cleaved by a furin endopeptidase in the trans-Golgi network. CC {ECO:0000250}. CC -!- SIMILARITY: Belongs to the peptidase M10A family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF131284; AAD42962.1; -; mRNA. DR EMBL; AB021227; BAA82967.1; -; mRNA. DR EMBL; AL121753; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS46593.1; -. DR RefSeq; NP_006681.1; NM_006690.3. DR AlphaFoldDB; Q9Y5R2; -. DR SMR; Q9Y5R2; -. DR BioGRID; 116099; 17. DR IntAct; Q9Y5R2; 2. DR MINT; Q9Y5R2; -. DR STRING; 9606.ENSP00000246186; -. DR BindingDB; Q9Y5R2; -. DR ChEMBL; CHEMBL5050; -. DR DrugBank; DB00786; Marimastat. DR MEROPS; M10.023; -. DR iPTMnet; Q9Y5R2; -. DR PhosphoSitePlus; Q9Y5R2; -. DR BioMuta; MMP24; -. DR DMDM; 12585280; -. DR EPD; Q9Y5R2; -. DR jPOST; Q9Y5R2; -. DR MassIVE; Q9Y5R2; -. DR MaxQB; Q9Y5R2; -. DR PaxDb; 9606-ENSP00000246186; -. DR PeptideAtlas; Q9Y5R2; -. DR ProteomicsDB; 86480; -. DR Antibodypedia; 5282; 228 antibodies from 30 providers. DR DNASU; 10893; -. DR Ensembl; ENST00000246186.8; ENSP00000246186.6; ENSG00000125966.10. DR GeneID; 10893; -. DR KEGG; hsa:10893; -. DR MANE-Select; ENST00000246186.8; ENSP00000246186.6; NM_006690.4; NP_006681.1. DR UCSC; uc002xbu.3; human. DR AGR; HGNC:7172; -. DR CTD; 10893; -. DR DisGeNET; 10893; -. DR GeneCards; MMP24; -. DR HGNC; HGNC:7172; MMP24. DR HPA; ENSG00000125966; Tissue enriched (brain). DR MIM; 604871; gene. DR neXtProt; NX_Q9Y5R2; -. DR OpenTargets; ENSG00000125966; -. DR PharmGKB; PA30881; -. DR VEuPathDB; HostDB:ENSG00000125966; -. DR eggNOG; KOG1565; Eukaryota. DR GeneTree; ENSGT00940000158315; -. DR HOGENOM; CLU_015489_8_1_1; -. DR InParanoid; Q9Y5R2; -. DR OMA; AMTQHYY; -. DR OrthoDB; 2225278at2759; -. DR PhylomeDB; Q9Y5R2; -. DR TreeFam; TF352396; -. DR PathwayCommons; Q9Y5R2; -. DR Reactome; R-HSA-1592389; Activation of Matrix Metalloproteinases. DR SignaLink; Q9Y5R2; -. DR SIGNOR; Q9Y5R2; -. DR BioGRID-ORCS; 10893; 37 hits in 1169 CRISPR screens. DR ChiTaRS; MMP24; human. DR GeneWiki; MMP24; -. DR GenomeRNAi; 10893; -. DR Pharos; Q9Y5R2; Tbio. DR PRO; PR:Q9Y5R2; -. DR Proteomes; UP000005640; Chromosome 20. DR RNAct; Q9Y5R2; Protein. DR Bgee; ENSG00000125966; Expressed in right hemisphere of cerebellum and 133 other cell types or tissues. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0031012; C:extracellular matrix; IEA:InterPro. DR GO; GO:0005615; C:extracellular space; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; ISS:UniProtKB. DR GO; GO:0032588; C:trans-Golgi network membrane; ISS:UniProtKB. DR GO; GO:0045296; F:cadherin binding; IEA:Ensembl. DR GO; GO:0008047; F:enzyme activator activity; TAS:ProtInc. DR GO; GO:0004222; F:metalloendopeptidase activity; ISS:UniProtKB. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0044331; P:cell-cell adhesion mediated by cadherin; ISS:UniProtKB. DR GO; GO:0098742; P:cell-cell adhesion via plasma-membrane adhesion molecules; ISS:UniProtKB. DR GO; GO:0030574; P:collagen catabolic process; IBA:GO_Central. DR GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; ISS:UniProtKB. DR GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central. DR GO; GO:0010001; P:glial cell differentiation; ISS:UniProtKB. DR GO; GO:0097150; P:neuronal stem cell population maintenance; ISS:UniProtKB. DR GO; GO:0006508; P:proteolysis; ISS:UniProtKB. DR CDD; cd00094; HX; 1. DR CDD; cd04278; ZnMc_MMP; 1. DR Gene3D; 3.40.390.10; Collagenase (Catalytic Domain); 1. DR Gene3D; 2.110.10.10; Hemopexin-like domain; 1. DR InterPro; IPR000585; Hemopexin-like_dom. DR InterPro; IPR036375; Hemopexin-like_dom_sf. DR InterPro; IPR018487; Hemopexin-like_repeat. DR InterPro; IPR018486; Hemopexin_CS. DR InterPro; IPR033739; M10A_MMP. DR InterPro; IPR024079; MetalloPept_cat_dom_sf. DR InterPro; IPR001818; Pept_M10_metallopeptidase. DR InterPro; IPR021190; Pept_M10A. DR InterPro; IPR021805; Pept_M10A_metallopeptidase_C. DR InterPro; IPR006026; Peptidase_Metallo. DR InterPro; IPR002477; Peptidoglycan-bd-like. DR InterPro; IPR036365; PGBD-like_sf. DR PANTHER; PTHR10201; MATRIX METALLOPROTEINASE; 1. DR PANTHER; PTHR10201:SF138; MATRIX METALLOPROTEINASE-24; 1. DR Pfam; PF11857; DUF3377; 1. DR Pfam; PF00045; Hemopexin; 4. DR Pfam; PF00413; Peptidase_M10; 1. DR Pfam; PF01471; PG_binding_1; 1. DR PIRSF; PIRSF001191; Peptidase_M10A_matrix; 1. DR PRINTS; PR00138; MATRIXIN. DR SMART; SM00120; HX; 4. DR SMART; SM00235; ZnMc; 1. DR SUPFAM; SSF50923; Hemopexin-like domain; 1. DR SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1. DR SUPFAM; SSF47090; PGBD-like; 1. DR PROSITE; PS00024; HEMOPEXIN; 1. DR PROSITE; PS51642; HEMOPEXIN_2; 4. DR PROSITE; PS00142; ZINC_PROTEASE; 1. DR Genevisible; Q9Y5R2; HS. PE 2: Evidence at transcript level; KW Calcium; Cell adhesion; Cell membrane; Cleavage on pair of basic residues; KW Disulfide bond; Extracellular matrix; Golgi apparatus; Hydrolase; Membrane; KW Metal-binding; Metalloprotease; Protease; Reference proteome; Repeat; KW Secreted; Signal; Transmembrane; Transmembrane helix; Zinc; Zymogen. FT SIGNAL 1..52 FT /evidence="ECO:0000255" FT PROPEP 53..155 FT /evidence="ECO:0000250" FT /id="PRO_0000028846" FT CHAIN 156..645 FT /note="Matrix metalloproteinase-24" FT /id="PRO_0000028847" FT CHAIN 156..581 FT /note="Processed matrix metalloproteinase-24" FT /evidence="ECO:0000250" FT /id="PRO_0000302758" FT TOPO_DOM 53..602 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 603..623 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 624..645 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REPEAT 377..425 FT /note="Hemopexin 1" FT REPEAT 426..471 FT /note="Hemopexin 2" FT REPEAT 473..521 FT /note="Hemopexin 3" FT REPEAT 522..569 FT /note="Hemopexin 4" FT REGION 1..26 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 323..380 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 137..144 FT /note="Cysteine switch" FT /evidence="ECO:0000250" FT MOTIF 643..645 FT /note="PDZ-binding" FT COMPBIAS 7..25 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 347..363 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 283 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 139 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /note="in inhibited form" FT /evidence="ECO:0000250" FT BINDING 282 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 286 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 292 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT SITE 581..582 FT /note="Cleavage; by furin" FT /evidence="ECO:0000250" FT DISULFID 380..569 FT /evidence="ECO:0000250" FT VARIANT 564 FT /note="R -> H (in dbSNP:rs751887)" FT /id="VAR_060166" SQ SEQUENCE 645 AA; 73231 MW; 06B2B76EA3DABB9D CRC64; MPRSRGGRAA PGPPPPPPPP GQAPRWSRWR VPGRLLLLLL PALCCLPGAA RAAAAAAGAG NRAAVAVAVA RADEAEAPFA GQNWLKSYGY LLPYDSRASA LHSAKALQSA VSTMQQFYGI PVTGVLDQTT IEWMKKPRCG VPDHPHLSRR RRNKRYALTG QKWRQKHITY SIHNYTPKVG ELDTRKAIRQ AFDVWQKVTP LTFEEVPYHE IKSDRKEADI MIFFASGFHG DSSPFDGEGG FLAHAYFPGP GIGGDTHFDS DEPWTLGNAN HDGNDLFLVA VHELGHALGL EHSSDPSAIM APFYQYMETH NFKLPQDDLQ GIQKIYGPPA EPLEPTRPLP TLPVRRIHSP SERKHERQPR PPRPPLGDRP STPGTKPNIC DGNFNTVALF RGEMFVFKDR WFWRLRNNRV QEGYPMQIEQ FWKGLPARID AAYERADGRF VFFKGDKYWV FKEVTVEPGY PHSLGELGSC LPREGIDTAL RWEPVGKTYF FKGERYWRYS EERRATDPGY PKPITVWKGI PQAPQGAFIS KEGYYTYFYK GRDYWKFDNQ KLSVEPGYPR NILRDWMGCN QKEVERRKER RLPQDDVDIM VTINDVPGSV NAVAVVIPCI LSLCILVLVY TIFQFKNKTG PQPVTYYKRP VQEWV //